Absci Series C

Absci leverages generative AI and synthetic biology to discover novel biology and create better biologics. Their AI Drug Creation Platform designs differentiated biologics, such as antibodies targeting prolactin receptors for hair regrowth, and partners with leaders across pharma, tech, and academia to develop therapeutics against challenging targets. Absci aims to accelerate the delivery of life-changing medicines to patients.